| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |